It sounds like science fiction, but a cure for cancer is developing much faster than people thought.
Heron has a technology that can be applied to thousands of drugs, but they have cast their initial monetary lot on improving a anti-nauseous drug for chemo patients. This is a great and noble cause, and I am certain it will be approved, but Heron must hurry for patients and for Heron.
Chemo will be replaced by vaccines in the very near future, and Heron keeps putting their approval and launch date further and further out -- quarters add up to years.
After approval, they will have proof of concept and marketability, but their biochronomer technology platform will require major funding to move forward on many drugs.
The time window for moving their largest asset forward is getting smaller.